• Katherine R Gerrald, Dave L Dixon, Debra J Barnette, and Virginia G Williams.
• Wake Forest University Baptist Medical Center, Medical Center Boulevard, Pharmacy Department, Winston Salem, NC 27157, USA.
• J Clin Lipidol. 2010 Mar 1; 4 (2): 120-5.

BackgroundHyperlipidemia is a significant, modifiable risk factor for developing coronary heart disease. Low-density lipoprotein cholesterol (LDL-C) goal achievement has improved overall, but many high-risk patients remain above the desired LDL-C goals. Published data have demonstrated the ability of pharmacist-managed lipid clinics to improve lipid management in a variety of clinical settings.ObjectiveThis observational analysis aimed to report the impact of a newly developed hospital-based, outpatient lipid clinic by the use of point-of-care testing on LDL-C goal attainment.MethodsA retrospective, observational analysis was conducted from February 2007 to December 2008. The primary outcome measure was the change in the proportion of patients who achieved their LDL-C goal at the end of the observation period compared with baseline.ResultsA total of 81 patients met study inclusion criteria. Mean duration of follow-up was 9.0 ± 4.9 (SD) months. At the end of the observation period, 82.9% of patients achieved their LDL-C goal compared with 55.3% at baseline (P < .0001). The mean LDL-C decreased from 103 ± 45 mg/dL at baseline to 82 ± 28 mg/dL at the end of the observation period (P < .0001).ConclusionAn outpatient hospital-based, pharmacist-managed lipid clinic improved LDL-C goal attainment. Our results are unique in that pharmacists used point-of-care testing to obtain lipid results for making therapy adjustments during the face-to-face visit.Copyright © 2010 National Lipid Association. Published by Elsevier Inc. All rights reserved.

24 keywords...

hide…